Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Merus N.V.MRUS · Entity 70740 | EVP, CBO & Head of Merus US | May 07, 2024 | May 09, 2024 |
| Rallybio CorpRLYB · Entity 6838 | Director | September 24, 2026 | September 29, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Merus N.V.
Report date May 07, 2024 · Filed May 09, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Share Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $36.09 · Expires 2034-01-31 | Direct | 107,300 |
Reported balance
After 2024-05-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-05-07 · Grant · Acquired 107,300 · Balance 107,300 F1: On February 1, 2024, the Board of Directors approved the grant of options to purchase the common shares, at an exercise price of $36.09 per share, subject to the Company's general meeting resolving upon, and the Board having implemented through an amendment to the Company's articles of association, an increase in the authorized share capital sufficient to satisfy the award set forth (the "Shareholder Approval Condition"). On May 7, 2024, the shareholders approved the amendment to the Company's articles of association, including the increase in the authorized share capital satisfying the Shareholder Approval Condition. F2: Options vest over a four-year period from January 1, 2024. 25% vest on January 1, 2025 and in 36 equal monthly installments thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: On February 1, 2024, the Board of Directors approved the grant of options to purchase the common shares, at an exercise price of $36.09 per share, subject to the Company's general meeting resolving upon, and the Board having implemented through an amendment to the Company's articles of association, an increase in the authorized share capital sufficient to satisfy the award set forth (the "Shareholder Approval Condition"). On May 7, 2024, the shareholders approved the amendment to the Company's articles of association, including the increase in the authorized share capital satisfying the Shareholder Approval Condition.
F2: Options vest over a four-year period from January 1, 2024. 25% vest on January 1, 2025 and in 36 equal monthly installments thereafter.
Rallybio Corp
Report date September 24, 2026 · Filed September 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 12,044 |
Ending reported balance
After 2026-09-24 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-09-24 · Exercise / conversion · Acquired 3,562 · Balance 3,562 Row 2 · 2026-09-24 · Exercise / conversion · Acquired 8,482 · Balance 12,044 |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.38 · Expires 2035-05-13 | Direct | 0 |
Reported balance
After 2026-09-24 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-24 · Exercise / conversion · Disposed 3,562 · Balance 0 |
| Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.60 · Expires 2035-01-02 | Direct | 0 |
Reported balance
After 2026-09-24 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-24 · Exercise / conversion · Disposed 8,482 · Balance 0 F2: This option was issued to the reporting person pursuant to the Company's 2021 Equity Incentive Plan in lieu of retainer fees of $47,500. F1: The option vests as to the underlying shares of Common Stock in 12 equal installments, each on the last day of each month of calendar year 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The option vests as to the underlying shares of Common Stock in 12 equal installments, each on the last day of each month of calendar year 2025.
F2: This option was issued to the reporting person pursuant to the Company's 2021 Equity Incentive Plan in lieu of retainer fees of $47,500.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 24, 2026 Filed Sep 29, 2026 01:00 UTC | Rallybio Corp RLYB · Entity 6838 | Exercise / conversionOption (Right to Buy) · Derivative | 8,482 | $5.60 Strike: $7.60 | $47,499.20 |
DisclosureSEC source: 0001193125-26-405753 · ownership.xml · derivative · entry 4 Liu Hui · CIK 0001790518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,482 shares Expires 2035-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: This option was issued to the reporting person pursuant to the Company's 2021 Equity Incentive Plan in lieu of retainer fees of $47,500. F1 · derivative.exercise_date: The option vests as to the underlying shares of Common Stock in 12 equal installments, each on the last day of each month of calendar year 2025. Read SEC document |
| September 24, 2026 Filed Sep 29, 2026 01:00 UTC | Rallybio Corp RLYB · Entity 6838 | Exercise / conversionOption (Right to Buy) · Derivative | 3,562 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001193125-26-405753 · ownership.xml · derivative · entry 3 Liu Hui · CIK 0001790518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 3,562 shares Expires 2035-05-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2026 Filed Sep 29, 2026 01:00 UTC | Rallybio Corp RLYB · Entity 6838 | Exercise / conversionCommon Stock | 8,482 | $7.60 | $64,463.20 |
DisclosureSEC source: 0001193125-26-405753 · ownership.xml · nonDerivative · entry 2 Liu Hui · CIK 0001790518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,044 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 24, 2026 Filed Sep 29, 2026 01:00 UTC | Rallybio Corp RLYB · Entity 6838 | Exercise / conversionCommon Stock | 3,562 | $2.38 | $8,477.56 |
DisclosureSEC source: 0001193125-26-405753 · ownership.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,562 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 13, 2025 Filed May 15, 2025 21:03 UTC | Rallybio Corp RLYB · Entity 6838 | GrantOption (Right to Buy) · Derivative | 28,500 | $0.00 Strike: $0.30 | $0.00 |
DisclosureSEC source: 0001739410-25-000081 · wk-form4_1747343015.xml · derivative · entry 1 Liu Hui · CIK 0001790518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,500 Underlying: Common Stock · 28,500 shares Expires 2035-05-13 F1 · derivative.exercise_date: The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 13, 2026 or the date of the Company's 2026 Annual Meeting of Stockholders. Read SEC document |
| January 02, 2025 Filed Jan 6, 2025 22:06 UTC | Rallybio Corp RLYB · Entity 6838 | GrantOption (Right to Buy) · Derivative | 67,857 | $0.70 Strike: $0.95 | $47,499.90 |
DisclosureSEC source: 0001739410-25-000005 · wk-form4_1736201159.xml · derivative · entry 1 Liu Hui · CIK 0001790518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,857 Underlying: Common Stock · 67,857 shares Expires 2035-01-02 F2 · price: This option was issued to the reporting person pursuant to the Company's 2021 Equity Incentive Plan in lieu of retainer fees of $47,500. F1 · derivative.exercise_date: The option vests as to the underlying shares of Common Stock in 12 equal installments, each on the last day of each month of calendar year 2025. Read SEC document |
| May 15, 2024 Filed May 17, 2024 21:05 UTC | Rallybio Corp RLYB · Entity 6838 | GrantOption (Right to Buy) · Derivative | 16,500 | $0.00 Strike: $1.91 | $0.00 |
DisclosureSEC source: 0001739410-24-000092 · wk-form4_1715979915.xml · derivative · entry 1 Liu Hui · CIK 0001790518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Stock · 16,500 shares Expires 2034-05-15 F1 · derivative.exercise_date: The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 15, 2025 or the date of the Company's 2025 Annual Meeting of Stockholders. Read SEC document |
| May 07, 2024 Filed May 9, 2024 16:30 UTC | Merus N.V. MRUS · Entity 70740 | GrantShare Option (right to buy) · Derivative | 107,300 | $0.00 Strike: $36.09 | $0.00 |
DisclosureSEC source: 0000950170-24-057098 · ownership.xml · derivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,300 Underlying: Common Shares · 107,300 shares Expires 2034-01-31 F1 · date: On February 1, 2024, the Board of Directors approved the grant of options to purchase the common shares, at an exercise price of $36.09 per share, subject to the Company's general meeting resolving upon, and the Board having implemented through an amendment to the Company's articles of association, an increase in the authorized share capital sufficient to satisfy the award set forth (the "Shareholder Approval Condition"). On May 7, 2024, the shareholders approved the amendment to the Company's articles of association, including the increase in the authorized share capital satisfying the Shareholder Approval Condition. F2 · derivative.exercise_date: Options vest over a four-year period from January 1, 2024. 25% vest on January 1, 2025 and in 36 equal monthly installments thereafter. Read SEC document |
| October 10, 2023 Filed Oct 11, 2023 16:09 UTC | Merus N.V. MRUS · Entity 70740 | GrantRestricted Stock Units · Derivative | 5,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-052619 · doc4.xml · derivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Underlying: Restricted Stock Units · 5,000 shares Expires not disclosed F1 · derivative.exercise_price: Restricted stock units vest in one installment on January 1, 2025. Restricted stock units convert to Issuer common stock on a one-to-one basis. There is no applicable conversion or exercise price. F1 · price: Restricted stock units vest in one installment on January 1, 2025. Restricted stock units convert to Issuer common stock on a one-to-one basis. There is no applicable conversion or exercise price. F1 · derivative.exercise_date: Restricted stock units vest in one installment on January 1, 2025. Restricted stock units convert to Issuer common stock on a one-to-one basis. There is no applicable conversion or exercise price. F1 · derivative.expiration_date: Restricted stock units vest in one installment on January 1, 2025. Restricted stock units convert to Issuer common stock on a one-to-one basis. There is no applicable conversion or exercise price. Read SEC document |
| May 17, 2023 Filed May 19, 2023 21:22 UTC | Rallybio Corp RLYB · Entity 6838 | GrantOption (Right to Buy) · Derivative | 15,490 | $0.00 Strike: $5.64 | $0.00 |
DisclosureSEC source: 0000899243-23-013398 · doc4.xml · derivative · entry 1 Liu Hui · CIK 0001790518 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,490 Underlying: Common Stock · 15,490 shares Expires 2033-05-17 F1 · derivative.exercise_date: The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 17, 2024 or the date of the Company's 2024 Annual Meeting of Stockholders. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 12:43 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionShare Option (right to buy) · Derivative | 98,085 | $0.00 Strike: $7.86 | $0.00 |
DisclosureSEC source: 0001209191-23-023878 · doc4.xml · derivative · entry 2 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 98,085 shares Expires 2023-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options vest over a four-year period commencing December 16, 2015. 25% vest after one year and in 36 equal monthly installments thereafter. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 12:43 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionCommon Shares | 98,085 | $7.86 | $770,948.10 |
DisclosureSEC source: 0001209191-23-023878 · doc4.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,016 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Exercise price is denominated in Euros. Exchange rate of 1.0915 used to convert to USD Read SEC document |
| February 02, 2023 Filed Feb 3, 2023 16:26 UTC | Merus N.V. MRUS · Entity 70740 | GrantShare Option (right to buy) · Derivative | 104,000 | $0.00 Strike: $16.07 | $0.00 |
DisclosureSEC source: 0001209191-23-006858 · doc4.xml · derivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 104,000 Underlying: Common Shares · 104,000 shares Expires 2033-02-02 F1 · derivative.exercise_date: Options vest over a four-year period from January 1, 2023. 25% vest on January 1, 2024 and in 36 equal monthly installments thereafter. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 23:29 UTC | Rallybio Corp RLYB · Entity 6838 | GrantOption (Right to Buy) · Derivative | 10,237 | $0.00 Strike: $6.19 | $0.00 |
DisclosureSEC source: 0000899243-23-001049 · doc4.xml · derivative · entry 1 Liu Hui · CIK 0001790518 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,237 Underlying: Common Stock · 10,237 shares Expires 2033-01-03 F1 · derivative.exercise_date: The option vests as to the underlying shares of Common Stock in 12 equal installments, each on the last day of each month of calendar year 2023. Read SEC document |
| May 24, 2022 Filed May 27, 2022 00:13 UTC | Rallybio Corp RLYB · Entity 6838 | GrantOption (Right to Buy) · Derivative | 2,240 | $0.00 Strike: $12.75 | $0.00 |
DisclosureSEC source: 0000899243-22-019835 · doc4.xml · derivative · entry 1 Liu Hui · CIK 0001790518 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,240 Underlying: Common Stock · 2,240 shares Expires 2032-05-24 F1 · derivative.exercise_date: The option was granted under the Company's 2021 Equity Incentive Plan. The option vests on the earlier of May 24, 2023 or the date of the Company's 2023 Annual Meeting of Stockholders. Read SEC document |
| April 04, 2022 Filed Apr 6, 2022 23:59 UTC | Rallybio Corp RLYB · Entity 6838 | GrantOption (Right to Buy) · Derivative | 26,880 | $0.00 Strike: $8.22 | $0.00 |
DisclosureSEC source: 0000899243-22-014167 · doc4.xml · derivative · entry 1 Liu Hui · CIK 0001790518 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,880 Underlying: Common Stock · 26,880 shares Expires 2032-04-04 F1 · derivative.exercise_date: The option is granted under the Company's 2021 Equity Incentive Plan. The option vests in three equal annual installments beginning on April 4, 2023. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 14:00 UTC | Merus N.V. MRUS · Entity 70740 | GrantShare Option (right to buy) · Derivative | 83,000 | $0.00 Strike: $24.61 | $0.00 |
DisclosureSEC source: 0001209191-22-006288 · doc4.xml · derivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,000 Underlying: Common Shares · 83,000 shares Expires 2032-01-31 F1 · derivative.exercise_date: Options vest over a four-year period from January 1, 2022. 25% vest on January 1, 2023 and in 36 equal monthly installments thereafter. Read SEC document |
| February 16, 2021 Filed Feb 18, 2021 16:00 UTC | Merus N.V. MRUS · Entity 70740 | GrantShare Option (right to buy) · Derivative | 75,000 | $0.00 Strike: $24.43 | $0.00 |
DisclosureSEC source: 0001209191-21-011774 · doc4.xml · derivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Shares · 75,000 shares Expires 2031-02-16 F1 · derivative.exercise_date: Options vest over a four-year period from January 1, 2021. 25% vest on January 1, 2022 and in 36 equal monthly installments thereafter. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionRestricted Share Unit · Derivative | 578 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-21-001947 · doc4.xml · derivative · entry 2 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 578 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. Read SEC document |
| January 04, 2021 Filed Jan 6, 2021 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionCommon Shares | 578 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-001947 · doc4.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,931 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionRestricted Share Unit · Derivative | 582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-061447 · doc4.xml · derivative · entry 2 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 578 Underlying: Common Shares · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. Read SEC document |
| December 01, 2020 Filed Dec 3, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionCommon Shares | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-061447 · doc4.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,353 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionRestricted Share Unit · Derivative | 582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-056873 · doc4.xml · derivative · entry 2 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,160 Underlying: Common Shares · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. Read SEC document |
| November 02, 2020 Filed Nov 4, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionCommon Shares | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-056873 · doc4.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,771 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionRestricted Share Unit · Derivative | 582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-053569 · doc4.xml · derivative · entry 2 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,742 Underlying: Common Shares · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. Read SEC document |
| October 01, 2020 Filed Oct 5, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionCommon Shares | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-053569 · doc4.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,189 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionRestricted Share Unit · Derivative | 582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-049361 · doc4.xml · derivative · entry 2 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,324 Underlying: Common Shares · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. Read SEC document |
| September 01, 2020 Filed Sep 3, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionCommon Shares | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-049361 · doc4.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,607 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionRestricted Share Unit · Derivative | 582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-045073 · doc4.xml · derivative · entry 2 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,906 Underlying: Common Shares · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionCommon Shares | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-045073 · doc4.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,025 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 16:05 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionRestricted Share Unit · Derivative | 582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-040999 · doc4.xml · derivative · entry 2 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,488 Underlying: Common Shares · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. Read SEC document |
| July 01, 2020 Filed Jul 6, 2020 16:05 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionCommon Shares | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-040999 · doc4.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,443 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionRestricted Share Unit · Derivative | 582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-033920 · doc4.xml · derivative · entry 2 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,070 Underlying: Common Shares · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. Read SEC document |
| June 01, 2020 Filed Jun 3, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionCommon Shares | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-033920 · doc4.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,861 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 01, 2020 Filed May 5, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionRestricted Share Unit · Derivative | 582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-027039 · doc4.xml · derivative · entry 2 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,652 Underlying: Common Shares · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. Read SEC document |
| May 01, 2020 Filed May 5, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionCommon Shares | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-027039 · doc4.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,279 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionRestricted Share Unit · Derivative | 582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-023076 · doc4.xml · derivative · entry 3 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,234 Underlying: Common Shares · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. Read SEC document |
| April 01, 2020 Filed Apr 3, 2020 16:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionCommon Shares | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023076 · doc4.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,697 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 17:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionRestricted Share Unit · Derivative | 582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-016194 · doc4.xml · derivative · entry 2 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,816 Underlying: Common Shares · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. Read SEC document |
| March 02, 2020 Filed Mar 4, 2020 17:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionCommon Shares | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-016194 · doc4.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,115 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 17:00 UTC | Merus N.V. MRUS · Entity 70740 | GrantShare Option (right to buy) · Derivative | 57,500 | $0.00 Strike: $18.61 | $0.00 |
DisclosureSEC source: 0001209191-20-010646 · doc4.xml · derivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,500 Underlying: Common Shares · 57,500 shares Expires 2030-02-14 F1 · derivative.exercise_date: Options vest over a four-year period from January 1, 2020. 25% vest on January 1, 2021 and in 36 equal monthly installments thereafter. Read SEC document |
| February 03, 2020 Filed Feb 4, 2020 17:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionRestricted Share Unit · Derivative | 582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-006433 · doc4.xml · derivative · entry 2 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,398 Underlying: Common Shares · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. Read SEC document |
| February 03, 2020 Filed Feb 4, 2020 17:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionCommon Shares | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-006433 · doc4.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,533 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 17:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionRestricted Share Units · Derivative | 582 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-20-001950 · doc4.xml · derivative · entry 2 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,980 Underlying: Common Shares · 582 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F1 · price: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. F2 · derivative.exercise_date: Restricted stock units vest over a four-year period until January 1, 2021, in equal monthly installments. F1 · derivative.expiration_date: Each restricted share unit represents a contingent right to receive one common share of the Issuer. Restricted share units do not have an expiration date. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 17:00 UTC | Merus N.V. MRUS · Entity 70740 | Exercise / conversionCommon Shares | 582 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-001950 · doc4.xml · nonDerivative · entry 1 Liu Hui · CIK 0001790518 · EVP, CBO & Head of Merus US 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,951 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.